Bio-techne CORP (TECH) Hedge Fund & Institutional Holdings (Q2 2026)

TECH ranks #961 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

599 institutions disclose a position in TECH, but none treat it as a major bet — even Hbk Investments L P, its most concentrated holder, allocates just 4.7% of its own portfolio to it.

Czech National Bank has added to its TECH position for two straight quarters, increasing it by $1.0M to reach $3.3M today.

Versant Capital Management, Inc has trimmed its TECH position for two straight quarters, cutting it by $312.1K while still holding $25.1K.

TECH is up 0.1% today, and institutions have been net buyers of $1.3B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

TECH posted net income of $181.9M over the trailing twelve months, and currently trades at a P/E of 62.7.

• Profitable — net income of $181.9M over the trailing twelve months
• Revenue declined 0.4% year over year
• Net income improved year over year, from $73.4M to $181.9M
• Generated $292.1M in positive operating cash flow
• Current ratio of 4.55x — enough short-term assets to cover short-term liabilities
• Liabilities run x equity — a highly leveraged balance sheet worth noting